Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy: Updated
Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 311-321
Open Access | Times Cited: 12

Showing 12 citing articles:

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients
Abdullah Al-Danakh, Mohammed Safi, Yuli Jian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 20
Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines
Christian Garde, Michail Angelos Pavlidis, Pablo Garcés Velástegui, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma
Shiho Hirose, Tetsuo Mashima, Xunmei Yuan, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 791-803
Open Access | Times Cited: 3
Ursolic acid inhibits glioblastoma through suppressing TGFβ-mediated epithelial-mesenchymal transition (EMT) and angiogenesis
Bo Hei, Ruen Liu, Meihua Li
Heliyon (2024) Vol. 10, Iss. 6, pp. e27722-e27722
Open Access | Times Cited: 3
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
Rajesh N. Gacche
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189020-189020
Closed Access | Times Cited: 9
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors
Ye Guo, Zishu Wang, Huan Zhou, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Evaluation of 89Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET
Bhasker Radaram, Sarah Glazer, Ping Yang, et al.
ACS Omega (2023) Vol. 8, Iss. 19, pp. 17181-17194
Open Access | Times Cited: 4
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
Dmitri Loukinov, Amanda L. Anderson, Mikayel Mkrtichyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5976-5976
Open Access | Times Cited: 2
Bispecific therapeutics: a state-of-the-art review on the combination of immune checkpoint ‎inhibition with costimulatory and non-checkpoint targeted therapy
Samin Mortaheb, Parmida Sadat Pezeshki, Nima Rezaei
Expert Opinion on Biological Therapy (2024), pp. 1-17
Closed Access
Endogenous viral elements constitute a complementary source of antigens for personalized cancer immunotherapy
Christian Garde, Michail Pavlidis, Pablo Garcés Velástegui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Mechanostimulation-induced integrin αvβ6 and latency associated peptide coupling activates TGF-β and regulates cancer metastasis and stemness
Udesh Dhawan, Weili Wang, Yuh‐Charn Lin, et al.
Nano Today (2023) Vol. 50, pp. 101882-101882
Open Access
Page 1

Scroll to top